Payden & Rygel Reduces Stock Position in Merck & Co., Inc. (NYSE:MRK)
Payden & Rygel decreased its stake in shares of Merck & Co., Inc. (NYSE:MRK – Free Report) by 18.3% during the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 195,950 shares of the company’s stock after selling 43,850 shares during the quarter. Merck & Co., […]
More Stories
OncoCyte (NASDAQ:OCX) Coverage Initiated at StockNews.com
Stock analysts at StockNews.com assumed coverage on shares of OncoCyte (NASDAQ:OCX – Get Free Report) in a research report issued...
Pentair’s (PNR) Sector Weight Rating Reiterated at KeyCorp
KeyCorp restated their sector weight rating on shares of Pentair (NYSE:PNR – Free Report) in a research note issued to...
Citigroup Upgrades Veeco Instruments (NASDAQ:VECO) to “Buy”
Citigroup upgraded shares of Veeco Instruments (NASDAQ:VECO – Free Report) from a neutral rating to a buy rating in a...
Alliance Global Partners Reaffirms “Neutral” Rating for Canoo (NASDAQ:GOEV)
Alliance Global Partners reiterated their neutral rating on shares of Canoo (NASDAQ:GOEV – Free Report) in a research report report...
Nano-X Imaging (NASDAQ:NNOX) Research Coverage Started at D. Boral Capital
D. Boral Capital assumed coverage on shares of Nano-X Imaging (NASDAQ:NNOX – Free Report) in a report issued on Monday,...
AT&T (NYSE:T) Stock Rating Upgraded by Royal Bank of Canada
Royal Bank of Canada upgraded shares of AT&T (NYSE:T – Free Report) from a sector perform rating to an outperform...